| Detected | Trial | Change |
|---|---|---|
| 2026-06-03 | NCT05681039 Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-27 | NCT04929223 A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of… |
Trial sites expanded: 76 -> 82 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05862285 | A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La… | Cancer | Recruiting |
| NCT05904886 | A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in… | Hepatocellular Carcinoma | Active, Not Recruiting |
| NCT04665856 | Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in… | Small Cell Lung Carcinoma | Active, Not Recruiting |
| NCT04543617 | A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable… | Esophageal Squamous Cell Carcinoma | Active, Not Recruiting |
| Phase 2 | |||
| NCT04958811 | Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced… | Non-squamous Non-small-cell Lung Cancer | Active, Not Recruiting |
| NCT06754501 | A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint… | Cancer | Active, Not Recruiting |
| NCT05009069 | A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant… | Rectal Neoplasms | Active, Not Recruiting |
| NCT05645692 | A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT… | Urothelial Cancer | Active, Not Recruiting |
| NCT03784326 | Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in… | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Active, Not Recruiting |
| NCT05805501 | A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With… | Renal Cell Carcinoma | Active, Not Recruiting |
| NCT05681039 | Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With… | Squamous Cell Carcinoma | Active, Not Recruiting |
| NCT05798663 | Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable… | NSCLC | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT04486352 | A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer | Endometrial Cancer | Recruiting |
| NCT05394337 | Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable… | Metastatic Malignancy | Recruiting |
| NCT04524871 | A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment… | Advanced Liver Cancers | Recruiting |
| NCT05286801 | Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or… | Atypical Teratoid/Rhabdoid Tumor | Active, Not Recruiting |
| Phase 1 | |||
| NCT04929223 | A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of… | Metastatic Colorectal Cancer | Recruiting |
| NCT06760481 | Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With… | Advanced Solid Malignancies | Active, Not Recruiting |